Home/Filings/5/0001437749-21-007839
5//SEC Filing

CODE KENNETH REAY 5

Accession 0001437749-21-007839

CIK 0000880242other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 4:08 PM ET

Size

17.0 KB

Accession

0001437749-21-007839

Insider Transaction Report

Form 5
Period: 2020-05-04
CODE KENNETH REAY
DirectorChief Technology Officer10% Owner
Transactions
  • Award

    Common Stock

    2020-12-31$0.12/sh+335,840$40,30124,443,647 total
  • Award

    Option to Purchase Common Stock

    2020-05-01+343,571408,571 total
    Exercise: $0.14From: 2020-05-01Exp: 2030-05-01Common stock (343,571 underlying)
Footnotes (4)
  • [F1]The total reflects the March 1, 2020, expiration of an option to purchase 200,000 shares of the Issuer's common stock.
  • [F2]Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares issued and the acquisition price per share).
  • [F3]Includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.
  • [F4]This total is as of the date of the filing of this Report.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001370684

Filing Metadata

Form type
5
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:08 PM ET
Size
17.0 KB